These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37187338)

  • 1. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
    Singh S; Wang JY; Heysell SK; McShane PJ; Wadle C; Shankar P; Huang HL; Pasipanodya J; Boorgula GD; Philley JV; Gumbo T; Srivastava S
    Int J Antimicrob Agents; 2023 Jul; 62(1):106847. PubMed ID: 37187338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of
    Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
    Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease.
    Singh S; Gumbo T; Boorgula GD; Shankar P; Heysell SK; Srivastava S
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068722. PubMed ID: 35976006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omadacycline therapy for Mycobacterium abscessus species infections.
    Ingram PR; Jones EE; Allen B; Murray RJ; Keehner TJ; Whitmore TJ
    Intern Med J; 2023 Dec; 53(12):2257-2263. PubMed ID: 36917124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
    Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
    J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant
    Singh S; Gumbo T; Boorgula GD; Thomas TA; Philley JV; Srivastava S
    Antimicrob Agents Chemother; 2024 Feb; 68(2):e0108023. PubMed ID: 38131673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series.
    Duah M; Beshay M
    Int J Infect Dis; 2022 Sep; 122():953-956. PubMed ID: 35798234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
    Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
    mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.
    Rizzo AR; Moniri NH
    BMC Infect Dis; 2022 Nov; 22(1):874. PubMed ID: 36419143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.
    Deshpande D; Magombedze G; Boorgula GD; Chapagain M; Srivastava S; Gumbo T
    J Infect Dis; 2024 Aug; 230(2):e230-e240. PubMed ID: 38036299
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill.
    Gumbo T; Cirrincione K; Srivastava S
    J Antimicrob Chemother; 2020 May; 75(5):1212-1217. PubMed ID: 32016429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
    Boorgula GD; Gumbo T; Singh S; McShane PJ; Philley JV; Srivastava S
    Tuberculosis (Edinb); 2024 Jul; 147():102519. PubMed ID: 38754247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
    Chapagain M; Pasipanodya JG; Athale S; Bernal C; Trammell R; Howe D; Gumbo T
    J Antimicrob Chemother; 2022 May; 77(6):1694-1705. PubMed ID: 35257162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
    Pasipanodya JG; Ogbonna D; Ferro BE; Magombedze G; Srivastava S; Deshpande D; Gumbo T
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.